Articles related to OPTOMETRY-MEDICAL INTERFACE
Managing Microcyst-Like Epithelial Keratopathy Related to Cancer Therapy
As we embrace the era of antibody-drug conjugates (ADCs) in cancer therapy, it’s crucial to understand their impact on ocular health. With ADCs like mirvetuximab offering new hope for ovarian cancer patients, effective partnerships between optometrists and oncologists are key to managing associated ocular adverse events.
Optometry October 30th 2023